tiprankstipranks
Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS

Barinthus Biotherapeutics (BRNS) Stock Investors

73 Followers
Based on 747,525 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold BRNS
On average, investors allocate 0.00% of their portfolios to BRNS
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 747,525 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding BRNS

2.1%
Last 7
Days
5.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding BRNS, out of 747,525 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

BRNS Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,193 investors who made their portfolios public
The table shows changes in BRNS in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

BRNS Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
ChargePoint Holdings
4.17%
-1.00%
-2.43%
833.60M
Consumer Cyclical
Marathon Digital Holdings
5.78%
-0.18%
+0.20%
6.75B
Financial
Riot Platforms
5.15%
-0.53%
+0.54%
3.47B
Financial
UiPath
3.29%
-1.66%
-2.81%
6.90B
Technology
DraftKings
5.81%
-1.48%
-2.00%
32.41B
Consumer Cyclical
Plug Power
5.02%
-1.49%
-3.21%
1.87B
Industrials
Airbnb
4.47%
-0.80%
+2.22%
95.31B
Consumer Cyclical
Raytheon Technologies
4.04%
-1.17%
-1.61%
136.69B
Industrials
Zscaler
3.82%
-1.05%
+1.72%
28.50B
Technology
Trade Desk
4.67%
-1.31%
+0.13%
46.96B
Technology
Based on the activity of 747,525 active portfolios
Open your Smart Portfolio

BRNS Investor Analysis

BRNS investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
4.5%
of BRNS holders
are under 35
Average Segment Performance
Average P/E Ratio20.77
Beta7.15
Dividend Yield6.79%
BRNS investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
63.6%
of BRNS holders
are between 35–55
Average Segment Performance
Average P/E Ratio19.59
Beta11.22
Dividend Yield6.44%
BRNS investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
31.8%
of BRNS holders
are over 55
Average Segment Performance
Average P/E Ratio19.41
Beta3.84
Dividend Yield7.80%
Overview of age group and performance of BRNS stock investors
See who invests in BRNS according to age group and performance.

FAQ

How many retail Investors hold BRNS?
<0.1% of TipRanks' retail investors hold BRNS in their portfolios.
    What is BRNS Investor Sentiment?
    BRNS’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of BRNS in the last 7 days?
      ▼ 2.1% of TipRanks' retail investors changed their holding of BRNS in the last 7 days.
        What percentage of retail investors changed their holding of BRNS in the last 30 days?
        ▼ 5.6% of TipRanks' retail investors changed their holding of BRNS in the last 30 days.
          What is the average age of retail investors who hold BRNS?
          The average age of BRNS Holders is between 35–55.
            What other stocks have BRNS investors also bought?
            BRNS Investors also bought CHPT, MARA, RIOT, PATH, DKNG, PLUG, ABNB, RTX, ZS, TTD.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              BCRXBioCryst
              CYTKCytokinetics
              DHRDanaher
              EWEdwards Lifesciences
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis